A public-private council report outlining industry views on Japan’s drug pricing systems drew little discussion at a meeting of the…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY New Finance Minister Vows Full Discussions with MHLW on FY2025 Revision
October 3, 2024
-
REGULATORY New Cabinet Might Move the Needle in Off-Year Debate: Industry Exec
October 2, 2024
-
REGULATORY Japan’s New PM Eyes Social Security Reform as Cabinet Unveiled
October 2, 2024
-
REGULATORY Takamaro Fukuoka Named as New Health Minister
October 1, 2024
-
REGULATORY Japan Compiles First Biosimilar Roadmap
October 1, 2024
-
ACADEMIA Pharmacies, Hospitals Scrambling to Address New LLP Coverage Rule, Concerns Swirl Around Misuse
October 1, 2024
-
REGULATORY Ishiba Elected as New LDP Leader, Hopes Are High for Medical and Pharma Policies
September 30, 2024
-
REGULATORY MHLW to Publish Info Necessary for Driving Biosimilar Switches in FY2025
September 27, 2024
-
REGULATORY Kisunla Subject to Prior Pricing Review as It Follows Leqembi’s Footsteps
September 26, 2024
-
REGULATORY Japan Approves Lilly’s Kisunla, Eisai’s ALS Med, Gilead’s Trodelvy, and Lots More
September 25, 2024
-
BUSINESS NHI-Market Price Gap on Narrowing Trend, but Results Remain Unpredictable
September 24, 2024
-
REGULATORY More Pregnant Cases Reported for COVID Meds, Panel Urges Greater Caution
September 24, 2024
-
BUSINESS Tsumura to Cover Return Costs for China Staff after Shenzhen Stabbing
September 24, 2024
-
REGULATORY MHLW to Update Decade-Old Generic Roadmap, Add Blueprint for Biosimilars
September 20, 2024
-
BUSINESS Asahi Kasei Pivots toward Drug Business in Healthcare to Drive Growth
September 19, 2024
-
BUSINESS UCB CEO Hails Positive Change in Japan’s Pharma Policy
September 19, 2024
-
BUSINESS GSK’s Multiple Myeloma Drug Blenrep Filed in Japan
September 18, 2024
-
REGULATORY 9 LDP Leader Candidates Showcase Pharma Agendas in Campaign
September 17, 2024
-
BUSINESS Eisai Set on Streamlining Operations to Drive Drug Innovation: COO
September 13, 2024
-
ORGANIZATION Pharma Industry Prepares List of 68 Lawmakers to Support in Likely Snap Poll
September 12, 2024
ページ
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…
Japan’s drug wholesalers are facing mounting financial pressure as rising logistics and procurement costs deepen losses on product distribution, even…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…